CTLNU | LNOBE | P value | |
---|---|---|---|
No. of patients (n) | 50 | 48 | |
Age (x̅ ±s, years) | 67±10.5 | 66±11.8 | 0.93 |
Side (R/L, n) | 26/24 | 20/28 | 0.86 |
Gender (F/M, n) | 30/20 | 25/23 | 0.92 |
Median ASA score (1/2/3, n) | 2/47/1 | 3/45/0 | 0.91 |
Location of tumor (n) | 0.89 | ||
Renal pelvis | 43 | 38 | |
Ureter | 7 | 10 | |
Operative time (x̅ ±s, min) | 98.5±40.3 | 132.4±60.2 | <0.01 |
Blood loss (x̅ ±s, ml) | 60.4±20.3 | 150.6±50.2 | <0.01 |
Postoperative pain score ( x̅ ±s) | |||
24 h after surgery | 1.93±1.2 | 2.04±1.5 | 0.22 |
48 h after surgery | 1.17±1.1 | 1.25±1.6 | 0.32 |
Length of hospital stay (x̅ ±s, d) | 5.3±2.2 | 8.1±2.3 | <0.01 |
Recovery of bowel function (x̅ ±s, d) | 1.8±0.8 | 2.1±0.7 | 0.89 |
Incision length (x̅ ±s, cm) | 6.3±1.2 | 11.5±3.2 | <0.01 |
Pathological stage (T1/T2/T3, n) | 6/23/1 | 5/18/1 | 0.86 |
Tumor grade (G1/G2/G3, n) | 5/22/3 | 8/18/4 | 0.83 |
Follow-up (x̅ ±s, m) | 27.5±9.5 | 30.2±8.2 | 0.92 |
Tumor recurrence (n) | |||
Intravesical tumor recurrence | 3 | 2 | 0.32 |
Extra-bladder recurrence | 3 | 1 | 0.22 |